HSK46575

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSK46575, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]